• Home
  • About IBT
    • IBT History
    • Management
    • Board of Directors
    • Advisory Board
    • Sustainability Policy
  • Pipeline
    • IBP-9414
    • IBP-1016
    • IBP-1118
    • IBP-1122
    • Expanded Access Policy for Investigational Drugs
  • Healthcare Professionals
  • Investors & Media
    • Shares
    • Share Issue
    • Ownership Structure
    • Corporate Governance
    • Calendar
    • Financial Reports
    • Press Releases
    • Investors & Media Contact
  • Contact Us
  • Career
IBT Logo IBT Logo
  • En
  • Sv
  • Home
  • About IBT
    • IBT History
    • Management
    • Board of Directors
    • Advisory Board
    • Sustainability Policy
  • Pipeline
    • IBP-9414
    • IBP-1016
    • IBP-1118
    • IBP-1122
    • Expanded Access Policy for Investigational Drugs
  • Healthcare Professionals
  • Investors & Media
    • Shares
    • Share Issue
    • Ownership Structure
    • Corporate Governance
    • Calendar
    • Financial Reports
    • Press Releases
    • Investors & Media Contact
  • Contact Us
  • Career

Home


We target diseases in premature infants or caused by antibiotic-resistant bacteria
Contact | info@ibtherapeutics.com
© Copyright Infant Bacterial Therapeutics AB 2026
Cookie Policy Privacy Policy Terms of Use